Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial. (2013)
Attributed to:
MRC Centre for Transplantation
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/leu.2012.360
PubMed Identifier: 23222369
Publication URI: http://europepmc.org/abstract/MED/23222369
Type: Journal Article/Review
Volume: 27
Parent Publication: Leukemia
Issue: 4
ISSN: 0887-6924